delcath systems inc (DCTH:NASDAQ CM)
Eamonn P. Hobbs
Chief Executive Officer, President, Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee, Antares Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 61 board members in 7 different organizations across 8 different industries.|
See Board Relationships
Mr. Eamonn P. Hobbs has been the Chief Executive Officer and President of Antares Pharma Inc. since June 2014. Mr. Hobbs served as the Chief Executive Officer and President of Delcath Systems, Inc. from July 2009 to September 10, 2013. He Co-founded AngioDynamics Inc., a subsidiary of E-Z-EM Inc. and served as its Chief Executive Officer and President from June 1996 to March 1, 2009. He served as Senior Vice President of Angio Dynamics since October 2002 and its Vice ...
810 Seventh AvenuePhone: 212-489-2100
New York, New York 10019
Board Members Memberships*
Former Vice Chairman of the Board
Former Chief Executive Officer, President and Director
Chief Executive Officer, President, Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee
University of Massachusetts Lowell
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|William M. Greenman||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Principal Financial Officer, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Gary R. Maharaj||Chief Executive Officer, President and Director|
|Robert C.E. Kill||Chairman, Chief Executive Officer and President|
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|$544.2K||Compensation as of Fiscal Year 2013.|